We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

YD DIAGNOSTICS

Specializes in the manufacture of total in vitro diagnostic products. Product applications include urinalysis, blood ... read more Featured Products: More products

Download Mobile App




Semiquantitative Urine Dipstick Evaluated for Microalbuminuria Screening

By LabMedica International staff writers
Posted on 21 Aug 2014
The urine microalbumin test is used as a screening test for the diagnosis of renal complications in diseases, such as diabetic nephropathy, cardiovascular disease, and hypertension.

A urine dipstick test that can conveniently and semiquantitatively measure concentrations of urine microalbumin and creatinine as well as the albumin/creatinine ratio (ACR) has been developed and the diagnostic performance of the dipstick evaluated. More...


Laboratory scientists at the University of Ulsan College of Medicine (Seoul, Republic of Korea) and their colleagues randomly selected 1,040 urine specimens that had been sent for ACR tests from July 1, 2011, to August 31, 2011. Albumin and creatinine tests were performed using random, midstream spot urine samples, and all tests were completed within two hours of urine collection. The results of the dipstick tests were compared with measurements obtained by a quantitative analyzer.

The newly introduced semiquantitative urine dipstick evaluated was the URiSCAN Super cassette ACR (URiSuper-ACR, YD Diagnostics Corp.; Yongin-si, Republic of Korea). Detection of albumin and creatinine in the URiSuper-ACR were performed using the dye-binding and metal complex methods, respectively. The color change made by the reaction was measured by the URiSCAN Super Plus reflectance meter. The Cobas Integra 800 quantitative analyzer (Roche Diagnostics; Rotkreuz Switzerland), which uses immunoturbidometric and the Jaffe-kinetic method, was used as the comparison methodology.

The URiSuper-ACR test showed 88.8% and 86.3% sensitivity and 90.1% and 93.8% specificity for albumin concentration and ACR, respectively and showed 91.1% and 92.6% positive predictive values. The concordance rate between URiSuper-ACR and Cobas Integra quantitative method for albumin and creatinine concentration within the same category were 78.4% and 67.1%, respectively, and for the ±1 category were 98.8% and 99.5%, respectively. For ACR, an 80.0% concordance rate was seen within the same category.

The authors concluded that in their evaluation study on a heterogeneous patient group, the URiSuper-ACR showed good diagnostic performance, such as excellent sensitivity, specificity, concordance rate with quantitative method, linearity, and precision, and this method could be used as an effective screening tool for the detection of microalbuminuria in clinical laboratories. The study was published in the July 2014 issue of the Journal of Clinical Laboratory Analysis.

Related Links:

University of Ulsan College of Medicine
YD Diagnostics Corp. 
Roche Diagnostics



Gold Member
Aspiration System
VACUSAFE
Online QC Software
Acusera 24•7
All-in-One Molecular System
AIO M160
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Immunology

view channel
Image:Proteomic tear-fluid analysis revealed abnormal patterns in proteins that regulate nerves and T cells in individuals with eye problems (Image Credit: Adobe Stock)

Diagnostic Models Detect Hidden Eye Abnormalities After Mild COVID-19

Persistent ocular symptoms after COVID-19 can severely affect reading, work, and daily tasks, yet standard eye exams often reveal no clear abnormalities. Patients experiencing photophobia, eye pain, and... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.